Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2022-10-13 00:00:00 ET · period of report 2022-10-11 · accession 0001104659-22-108559 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-13 | 2022-10-11 | INSP | Herbert Timothy P. | CEO, Pres, Dir | M - OptEx | $4.74 | +68.8K | 118.7K | +138% | +$326.3K |
| DM | 2022-10-13 | 2022-10-11 | INSP | Herbert Timothy P. | CEO, Pres, Dir | M - OptEx | $0.00 | -68.8K | 85.0K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-11 | M | A | 41,216 | $0.94 | 159,895 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-11 | M | A | 42 | $42.15 | 159,937 | D | — | — | |
| 3 | Common | Common Stock | 2022-10-11 | M | A | 27,529 | $10.38 | 118,679 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-10-11 | M | D | 27,529 | $0.00 | 85,252 | D | $10.38 · — to 2028-04-09 | 27,529 Common Stock | (F4) The option is fully vested and exercisable. (F5) This option grant was previously reported as having an expiration date of April 8, 2028, which has been revised herein. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-10-11 | M | D | 41,216 | $0.00 | 0 | D | $0.94 · — to 2027-04-01 | 41,216 Common Stock | (F6) Following the reported transactions, there are no remaining options held under this grant by the Reporting Person, either directly or indirectly. (F4) The option is fully vested and exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-10-11 | M | D | 42 | $0.00 | 84,958 | D | $42.15 · — to 2028-12-18 | 42 Common Stock | (F7) The option vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 18, 2018 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |